{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT00666341",
      "orgStudyIdInfo": {
        "id": "AL0701rP"
      },
      "secondaryIdInfos": [
        {
          "id": "2007-002808-18",
          "type": "EUDRACT_NUMBER"
        }
      ],
      "organization": {
        "fullName": "Allergopharma GmbH & Co. KG",
        "class": "INDUSTRY"
      },
      "briefTitle": "Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens",
      "officialTitle": "A Double-blind Placebo-controlled Dose-response Study for Evaluation of Safety and Efficacy of Immunotherapy With a Cocktail of Recombinant Major Allergens of Timothy Grass Pollen (Phleum Pratense) Adsorbed to Aluminium Hydroxide in Patients With IgE-mediated Allergic Rhinitis/Rhinoconjunctivitis With or Without Bronchial Asthma"
    },
    "statusModule": {
      "statusVerifiedDate": "2013-11",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2007-09"
      },
      "primaryCompletionDateStruct": {
        "date": "2009-01",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2010-05",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2008-04-21",
      "studyFirstSubmitQcDate": "2008-04-23",
      "studyFirstPostDateStruct": {
        "date": "2008-04-24",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2013-11-07",
      "lastUpdatePostDateStruct": {
        "date": "2013-11-08",
        "type": "ESTIMATED"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "Allergopharma GmbH & Co. KG",
        "class": "INDUSTRY"
      }
    },
    "oversightModule": {
      "oversightHasDmc": true
    },
    "descriptionModule": {
      "briefSummary": "Dose-response trial with a cocktail of recombinant major allergens of Timothy Grass Pollen (Phleum pratense)"
    },
    "conditionsModule": {
      "conditions": [
        "Type I-Allergy"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "TRIPLE",
          "whoMasked": [
            "PARTICIPANT",
            "INVESTIGATOR",
            "OUTCOMES_ASSESSOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 50,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Placebo",
          "type": "PLACEBO_COMPARATOR",
          "description": "Placebo: Al(OH)3-Placebos with histamine-dihydrochloride analogue Allergen-Adsorbate rPhleum strengthes 1 to 4.",
          "interventionNames": [
            "Drug: placebo"
          ]
        },
        {
          "label": "20 μg rPhleum Immunotherapy",
          "type": "EXPERIMENTAL",
          "description": "Cocktail of recombinant major allergens of Phleum pratense (timothy grass) with strength 1 (20 μg)",
          "interventionNames": [
            "Biological: rPhleum"
          ]
        },
        {
          "label": "40 μg rPhleum Immunotherapy",
          "type": "EXPERIMENTAL",
          "description": "Cocktail of recombinant major allergens of Phleum pratense (timothy grass) with strength 2 (40 μg)",
          "interventionNames": [
            "Biological: rPhleum"
          ]
        },
        {
          "label": "80 μg rPhleum Immunotherapy",
          "type": "EXPERIMENTAL",
          "description": "Cocktail of recombinant major allergens of Phleum pratense (timothy grass) with strength 3 (80 μg)",
          "interventionNames": [
            "Biological: rPhleum"
          ]
        },
        {
          "label": "120 μg rPhleum Immunotherapy",
          "type": "EXPERIMENTAL",
          "description": "Cocktail of recombinant major allergens of Phleum pratense (timothy grass) with strength 4 (120 μg)",
          "interventionNames": [
            "Biological: rPhleum"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "placebo",
          "description": "Placebo: Al(OH)3-Placebos with histamine-dihydrochloride analogue Allergen-Adsorbate rPhleum strengthes 1 to 4.",
          "armGroupLabels": [
            "Placebo"
          ],
          "otherNames": [
            "Comparator"
          ]
        },
        {
          "type": "BIOLOGICAL",
          "name": "rPhleum",
          "description": "Cocktail of recombinant major allergens of Phleum pratense (timothy grass) with strength 1 (20 μg)",
          "armGroupLabels": [
            "20 μg rPhleum Immunotherapy"
          ],
          "otherNames": [
            "Specific Immunotherapy"
          ]
        },
        {
          "type": "BIOLOGICAL",
          "name": "rPhleum",
          "description": "Cocktail of recombinant major allergens of Phleum pratense (timothy grass) with strength 2 (40 μg)",
          "armGroupLabels": [
            "40 μg rPhleum Immunotherapy"
          ],
          "otherNames": [
            "Specific Immunotherapy"
          ]
        },
        {
          "type": "BIOLOGICAL",
          "name": "rPhleum",
          "description": "Cocktail of recombinant major allergens of Phleum pratense (timothy grass) with strength 3 (80 μg)",
          "armGroupLabels": [
            "80 μg rPhleum Immunotherapy"
          ],
          "otherNames": [
            "Specific Immunotherapy"
          ]
        },
        {
          "type": "BIOLOGICAL",
          "name": "rPhleum",
          "description": "Cocktail of recombinant major allergens of Phleum pratense (timothy grass) with strength 4 (120 μg)",
          "armGroupLabels": [
            "120 μg rPhleum Immunotherapy"
          ],
          "otherNames": [
            "Specific Immunotherapy"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Systemic reaction (according to Tryba)",
          "description": "Number of patients with at least one systemic reaction (according to Tryba Grade 1-4) with possible, probable or definite relationship to the study medication determined at the end of the uptitration phase.",
          "timeFrame": "uptitration phase"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Late Phase Reactions",
          "description": "Changes of the Late Phase Reactions in specific intracutaneous test with natural allergen before and at the end of the double-blind placebo controlled phase before grass pollen season.",
          "timeFrame": "before and at the end of the double-blind phase"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* main symptoms of allergic rhinitis/rhinoconjunctivitis with or without controlled asthma against grass pollen allergens\n* positive SPT\n* positive EAST\n* positive specific provocation test\n\nExclusion Criteria:\n\n* serious chronic diseases\n* other perennial allergies",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "maximumAge": "50 Years",
      "stdAges": [
        "ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Karl Hörmann, MD",
          "affiliation": "Universitätsklinikum Mannheim GMBH",
          "role": "STUDY_CHAIR"
        }
      ],
      "locations": [
        {
          "facility": "Prof. Dr. med. Ludger Klimek",
          "city": "Wiesbaden",
          "state": "Baden-W.",
          "zip": "68167",
          "country": "Germany",
          "geoPoint": {
            "lat": 50.08601,
            "lon": 8.24435
          }
        }
      ]
    },
    "referencesModule": {
      "seeAlsoLinks": [
        {
          "label": "Leader in specific allergy research and therapy",
          "url": "http://www.allergopharma.de"
        },
        {
          "label": "Click here for information about this trial in the European Clinical Trials Register",
          "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-002808-18/DE"
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    }
  },
  "hasResults": false
}